Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Myriad Genetics Inc

NASDAQ: MYGN · Life Sciences · 8 alerts · CIK 899923

Share price
$5.57Close, Nov 16
Market cap
$534M
Shares outstanding
95.92MLatest SEC cover page
Sector
Life Sciences
Industry
In Vitro & In Vivo Diagnostic SubstancesSIC 2835

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Myriad Genetics Inc filings on SEC EDGAR ↗

8:37 AM ET 8-K
Divestiture

Myriad Genetics Divestiture to Laboratory Corporation of America for $210M

Myriad Genetics has entered into a definitive agreement to sell its prenatal health testing business, including the Foresight, Prequel, and SneakPeek tests, to Labcorp for $210 million in cash. The divestiture is part of a strategic review to focus on the company's cancer care continuum and is expected to close by early 2027.

Value
$210M
Counterparty
Laboratory Corporation of America

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.